CLRB

Cellectar Biosciences CLRB Stock News

Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio Breast Cancer Symposium

Efficacy established in 4th class of molecules utilizing Phospholipid Ether Vehicle FLORHAM PARK, N.J., Dec. 13, 2019 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage… Read More »Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio Breast Cancer Symposium